Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (Stage IIIA-N2): Impact of adjuvant therapies in a subset of patients at high risk of recurrence
CancerPublished 1 August 1996Open access
Carlo Alberto Angeletti, Marco Lucchi, Gabriella Fontanini, Alfredo Mussi, Antonio Chella, Alessandro Ribechini
Citations70
SJR quartileQ1
SJR score2.95
SNIP1.90
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Microvessel count, as a measure of tumor angiogenesis, has been significantly correlated with metastatic disease in cutaneous, mammary, prostatic, head and neck, and early stage lung carcinoma.
Abstract
Our results provide evidence that neovascularization, estimated by the MC, can predict metastatic disease and survival in patients with completely resected T1-3N2M0 NSCLC, and may also be useful in patient selection for effective adjuvant treatment.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
Springer series in statisticsNonparametric Estimation from Incomplete Observations
45,533 Citations1992Edward L. Kaplan, Paul Meier
Journal of the American Statistical AssociationNonparametric Estimation from Incomplete Observations
39,052 Citations1958Edward L. Kaplan, Paul Meier
New England Journal of MedicineTumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
5,654 Citations1991Noel Weidner, Joseph P. Semple +2 more
The number of microvessels per 200x field in the areas of most intensive neovascularization in an invasive breast carcinoma may be an independent predictor of metastatic disease either in axillary lymph nodes or at distant sites (or both).
JNCI Journal of the National Cancer InstituteWhat Is the Evidence That Tumors Are Angiogenesis Dependent?
4,570 Citations1990Judah Folkman
Method of treating a wound or burn which comprises directly dressing its surface with non-woven fabric comprising staple fibers of spun, regenerated collagen substantially free of telopeptides is disclosed.
NatureInhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
3,608 Citations1993K. Jin Kim, Bing Li +5 more
It is demonstrated that inhibition of the action of an angiogenic factor spontaneously produced by tumour cells may suppress tumour growth in vivo.
CellAngiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
3,339 Citations1994M. OʼReilly
It is shown that the inhibition of metastases by a primary mouse tumor is mediated, at least in part, by angiostatin, and a corresponding fragment of human plasminogen has similar activity.
JNCI Journal of the National Cancer InstituteTumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma
1,794 Citations1992Noel Weidner, J Folkman +6 more
Microvessel density in the area of the most intense neovascularization in invasive breast carcinoma is an independent and highly significant prognostic indicator for overall and relapse-free survival in patients with early-stage breast carcinom (I or II by International Union Against Cancer criteria).
CHEST JournalA New International Staging System for Lung Cancer
1,665 Citations1986Clifton F. Mountain
The International Staging System for Lung Cancer provides for classification of six levels of disease extent in five stage groups that relate to patient management and prognosis and can be readily applied in a broad spectrum of clinical and teaching environments.
PubMedTumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
1,635 Citations1993Noel Weidner, Peter R. Carroll +3 more
Assay of microvessel density within invasive tumors may prove valuable in selecting patients for aggressive adjuvant therapies in early prostate carcinoma, and was present predominantly in the poorly differentiated tumors.
NatureSynthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
1,301 Citations1990Donald E. Ingber, Takeshi Fujita +5 more
Synthesis of fumagillin analogues yielded potent angiogenesis inhibitors ('angioinhibins') which suppress the growth of a wide variety of tumours with relatively few side-effects.
New England Journal of MedicineA Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer
1,264 Citations1994R. Rosell, José Gómez‐Codina +13 more
Preoperative chemotherapy increases the median survival in patients with non-small-cell lung cancer, and the prevalence of mutated K-ras oncogenes was 15 percent among the patients receiving preoperative chemotherapy and 42 percent among those treated with surgery alone.
PubMedIntratumor microvessel density as a prognostic factor in cancer.
876 Citations1995Noel Weidner
Analysis of tumor neovascularization in advanced stage ovarian cancer may be a useful prognostic marker and indirect and direct evidence is presented to show that tumor growth is angiogenesis dependent, that tumor cells can produce diffusible angiogenic regulatory molecules, and thatAngiogenesis antagonists can slow or prevent tumor growth.
The LancetRelation of neovascularisation to metastasis of non-small-cell lung cancer
770 Citations1992Paolo Macchiarini, Gabriella Fontanini +3 more
Both microvessel count and density grades correlated significantly with metastatic disease as well as tumour size and proliferative activity, and the likelihood of metastasis increased as the vessel count increased.
Journal of Thoracic and Cardiovascular SurgeryPrognosis and survival in resected lung carcinoma based on the new international staging system
691 Citations1988Tsuguo Naruke, Tomoyuki Goya +2 more
In both the clinical stage and the postoperative stage, there were significant prognostic differences between stage I and stage II, stage II andStage IIIA, andstage IIIA and stage IIIB, but there was no significant difference in 5-year survival rates between stageIIIB and stage IV.
American Journal of Clinical PathologyThe World Health Organization Histological Typing of Lung Tumours: Second Edition
668 Citations1982
The WHO Histological Classification of Lung Tumours, published in 1967, has been revised and a number of less common tumours and tumour-like lesions are defined.
PubMedThe prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study.
535 Citations1988Anurag Srivastava, P. Laidler +3 more
It is suggested that increased vascularity at the tumor base may have prognostic significance in intermediate thickness melanomas.
Surgical Clinics of North AmericaThe Role of Surgery in N2 Lung Cancer
428 Citations1987Nael Martini, Betty J. Flehinger
Data is presented to support the view that a significant number of patients with mediastinal lymph node metastases do have resectable tumors with encouraging long-term survival results and steps identified to guide the physicians in selecting the patients who can benefit from this surgical approach.
New England Journal of MedicineEffects of Postoperative Mediastinal Radiation on Completely Resected Stage II and Stage III Epidermoid Cancer of the Lung
412 Citations1986The Lung Cancer Study Group
It is concluded that radiotherapy can reduce local recurrences after resection of epidermoid carcinoma of the lung, but that it does not increase survival rates.
PubMedTumor angiogenesis in advanced stage ovarian carcinoma.
388 Citations1995Helen C. Hollingsworth, Elise C. Kohn +3 more
Analysis of neovascularization in advanced stage ovarian cancer may be a useful prognostic factor and with the Cox proportional hazards model, stage was the best predictor of overall survival, however, the average microvessel count at 400x was found to be thebest predictor of disease-free survival.
The Annals of Thoracic SurgeryPreoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients
372 Citations1993Nael Martini, Mark G. Kris +10 more
It is demonstrated that preoperative chemotherapy with MVP produces high response rates in stage IIIa (N2) disease, high complete resection rates occur after response to chemotherapy, and survival is longest in patients who have acomplete resection after major response to chemo.
International Journal of CancerIntratumoral microvessel density and L53 protein: Correlation with metastasis in head‐and‐neck squamous‐cell carcinoma
307 Citations1993Giampietro Gasparini, Noel Weidner +6 more
Multivariate analysis showed that both vascularity and stage, but not p53 expression, are significant and independent predictors of metastasis in this series.
PubMedInhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo.
208 Citations1993Toshihiko Yanase, Masaoki Tamura +3 more
Lung metastasis of GCH-1(m) cells was strongly inhibited both in the number and in the size of tumor nodules, indicating that the capillary growth in the originally developed tumor was also significantly reduced.
Journal of Clinical OncologyThe benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group.
190 Citations1988
Analysis of sites of recurrence showed a significant decrease in distant metastases in the chemotherapy arm and a 14% difference in survival rate favoring the chemotherapy side 1 year after randomization.
The Journal of PathologyMicrovessel count predicts metastatic disease and survival in non‐small cell lung cancer
183 Citations1995Gabriella Fontanini, D Bigini +8 more
The overall survival analysis calculated by the Kaplan‐Meier method revealed that tumours with high MC were significantly associated with increased death risk, and patients who developed metastasis during follow‐up showed a higher MC than patients who had developed no metastasis at the time of the analysis.
PubMedSurgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.
179 Citations1993Valerie W. Rusch, Kathy S. Albain +7 more
Journal of Thoracic and Cardiovascular SurgerySurgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease)
171 Citations1994Peter Goldstraw, Gopi C. Mannam +2 more
It is believed resection is justified in patients with non-small-cell lung carcinoma, who have already incurred the morbidity and mortality of thoracotomy, so long as complete resections are possible.
CancerTumor angiogenesis in human lung adenocarcinoma
167 Citations1994Kohichi Yamazaki, Hironori Takekawa +8 more
Journal of Thoracic and Cardiovascular SurgerySurgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy
161 Citations1993Valerie W. Rusch, Kathy S. Albain +7 more
This combined modality therapy has been well tolerated and has been associated with high response and resectability rates in both stage IIIA and stage IIIB non-small-cell lung cancer, providing a firm basis for subsequent phase III clinical trials.
Journal of Thoracic and Cardiovascular SurgeryBlood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer
118 Citations1993Paolo Macchiarini, Gabriella Fontanini +6 more
The results provide a rationale for effective systemic adjuvant treatment in completely resected T1 N0 M0 non-small-cell lung cancer tailored to the individual patients' risk of development of recurrent non- Small Cell lung cancer.
CHEST JournalMediastinal Nodal Involvement and the Prognosis of Non-Small Cell Lung Cancer
98 Citations1991Yoh Watanabe, Yoshinobu Hayashi +3 more
The survival of patients with N2 disease was affected by the operative radicality, by the number of levels of metastases, and also by the location of the nodal involvement, it seems appropriate that extensive mediastinal dissection should be performed irrespective of the locations of the primary tumor.
Journal of Thoracic and Cardiovascular SurgeryMost peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion
58 Citations1992Paolo Macchiarini, Gabriella Fontanini +3 more
Data demonstrate that peripheral, node-negative non-small-cell lung cancers have a low metastatic potential and Whenever anatomically feasible, wedge resection seems to be an appropriate method of primary treatment.
The Annals of Thoracic SurgeryPrognosis of unsuspected but completely resectable N2 non-small cell lung cancer
53 Citations1993R.J. van Klaveren, Jan Festen +4 more
It is concluded that patients with unsuspected stage IIIa non-small cell lung cancer discovered at thoracotomy benefit from complete tumor resection and mediastinal lymph node dissection, especially if the resection can be confined to lobectomy and if the tumor is located centrally.
The Annals of Thoracic SurgeryInduction chemotherapy for locally advanced non-small cell lung cancer
38 Citations1993Frances A. Shepherd
The studies reviewed showed that induction therapy followed by surgical resection is feasible and is not associated with unacceptable toxicity, and until randomized trials are undertaken, induction therapy and surgical intervention for locally advanced non-small lung cancer must be viewed as experimental.
Lung CancerPostoperative adjuvant treatments for non-small cell lung cancers: a consensus report
28 Citations1991E. Carmack Holmes, N M Bleehen +10 more
The Committee met at the time of the International Association for the Study of Lung Cancer in Belgium to discuss the current status of postoperative adjuvant therapy for completely resected non-small cell lung cancer agreed unanimously that both postoperative chemotherapy and radiation therapy are unproven treatment modalities and should be considered under investigation.
CHEST JournalPostoperative Chemotherapy for Non-Small-Cell Lung Cancer
23 Citations1993E. Carmack Holmes
The Lung Cancer Study Group has performed a number of postoperative adjuvant trials in patients with resectable non-small-cell lung cancer and found the chemotherapy arm had significantly increased disease-free survival.
European Journal of Surgical OncologyPre-operative chemotherapy for stage IIIa (N2) non-small cell lung cancer
7 Citations1995Antonio Chella, Marco Lucchi +5 more
The results confirm the high response rate of CHT, as well as the feasibility and the overall low complication rate of both treatments (CHT and surgery); and the feasibility of surgery, patterns of disease recurrence and survival after neoajuvant chemotherapy in NSCLC stage IIIA-N2.